Evidence map›Paper›PMID 29739889›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress.

Sujuan Xu, Shizheng Huang, Zhilin Luan, Tingyue Chen, Yuanyi Wei, Miaomiao Xing, Yaqing Li, Chunxiu Du, Bing Wang, Feng Zheng and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Role of FXR in Renal Physiology and Kidney Diseases.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Bile acids and salt-sensitive hypertension: a role of the gut-liver axis.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  9. Review
  10. Article
  11. Update on FXR Biology: Promising Therapeutic Target?International journal of molecular sciences · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 3 countries.

Sujuan XuAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Shizheng HuangRenal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Zhilin LuanAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Tingyue ChenAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Yuanyi WeiAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Miaomiao XingAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Yaqing LiAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Chunxiu DuAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Bing WangAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Feng ZhengAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Nanping WangAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China.
Youfei GuanAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China; guanyf@dmu.edu.cn jgustafs@central.uh.edu zhangxy@dmu.edu.cn.
Jan-Åke GustafssonCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204; guanyf@dmu.edu.cn jgustafs@central.uh.edu zhangxy@dmu.edu.cn.
Xiaoyan ZhangAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044 Liaoning, China; guanyf@dmu.edu.cn jgustafs@central.uh.edu zhangxy@dmu.edu.cn.
Dalian Medical University · CNUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertonicity in renal medulla is critical for the kidney to produce concentrated urine. Renal medullary cells have to survive high medullary osmolarity during antidiuresis. Previous study reported that farnesoid X receptor (FXR), a nuclear receptor transcription factor activated by endogenous bile acids, increases urine concentrating ability by up-regulating aquaporin 2 expression in medullary collecting duct cells (MCDs). However, whether FXR is also involved in the maintenance of cell survival of MCDs under dehydration condition and hypertonic stress remains largely unknown. In the present study, we demonstrate that 24-hours water restriction selectively up-regulated renal medullary expression of FXR with little MCD apoptosis in wild-type mice. In contrast, water deprivation caused a massive apoptosis of MCDs in both global FXR gene-deficient mice and collecting duct-specific FXR knockout mice. In vitro studies showed that hypertonicity significantly increased FXR and tonicity response enhancer binding protein (TonEBP) expression in mIMCD3 cell line and primary cultured MCDs. Activation and overexpression of FXR markedly increased cell viability and decreased cell apoptosis under hyperosmotic conditions. In addition, FXR can increase gene expression and nuclear translocation of TonEBP. We conclude that FXR protects MCDs from hypertonicity-induced cell injury very likely via increasing TonEBP expression and nuclear translocation. This study provides insights into the molecular mechanism by which FXR enhances urine concentration via maintaining cell viability of MCDs under hyperosmotic condition.

Indexed as

Stress, PhysiologicalAnimalsGene Expression RegulationKidney Concentrating AbilityKidney MedullaKidney Tubules, CollectingMaleMiceMice, Inbred C57BLMice, KnockoutOsmotic PressureReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearTranscription FactorsNfat5 protein, mouseReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearTranscription Factorsbile acid receptorcell viabilityhypertonicityNFAT5osmoprotection

Identifiers

PMID29739889
PMCPMC6003498
OpenAlexW2799522520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.